Update
$Zevra Therapeutics(ZVRA.US$ Zevra Therapeutics Announces Top-Line Data from the Phase 2 Clinical Trial of KP1077 for Idiopathic Hypersomnia
3 MINUTES AGO, 4:30 PM EDT
VIA GLOBENEWSWIRE
KP1077 demonstrates clinically meaningful benefits for key IH symptoms
Top-line data provide key information for the design of a Phase 3 study
3 MINUTES AGO, 4:30 PM EDT
VIA GLOBENEWSWIRE
KP1077 demonstrates clinically meaningful benefits for key IH symptoms
Top-line data provide key information for the design of a Phase 3 study
Disclaimer: Community is offered by Moomoo Technologies Inc. and is for educational purposes only.
Read more
Comment
Sign in to post a comment
